Overall, arthritis was significantly more common (according to logistic regression analysis) in patients requiring biological therapy, and patients with arthritis detected at the onset of their CD (n = 18) received more aggressive treatment, including the TNF-inhibitor biologic infliximab. The gene discussed is TNF; the disease is Arthritis.